CDE Detailed Report
Disease: content
Subdomain Name: Drugs
CRF: welcome
Displaying 1 - 50 of 72
Subdomain Name: Drugs
CRF: welcome
Displaying 1 - 50 of 72
| CDE ID | CDE Name | Variable Name | Definition | Short Description | Question Text | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guidance) | Subdomain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | External Id Loinc | External Id Snomed | External Id caDSR | External Id CDISC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C58999 | Medication cold preparation current former take indicator | MedctnColdPrepCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken cold preparations/ medications | The indicator relating to whether the subject/participant has formerly or currently taken cold preparations/ medications | Cold preparations/ medications | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
This element is recommended for pediatric stroke studies. |
No references available | Pediatric | Exploratory | 1.00 | 2020-08-13 15:42:22.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58967 | Medication cholesterol reduce control current former take indicator | MedctnCholRdcCtrlCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken cholesterol-reducing/ controlling medications | The indicator relating to whether the subject/participant has formerly or currently taken cholesterol-reducing/ controlling medications | Cholesterol-reducing/ controlling medications | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation? |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:43:16.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C54985 | Stimulant current former use type | StimulantCurrFrmrUseTyp | Type of stimulant formerly or currently taken by the subject/participant | Type of stimulant formerly or currently taken by the subject/participant | Stimulants | Amphetamine derivatives;Caffeine;Theophylline;Modafinil;Other, specify;Phentermine | Amphetamine derivatives;Caffeine (Xanthine derivative);Theophylline (Xanthine derivative);Modafinil;Other, specify;Phentermine | Alphanumeric |
Was the participant/ subject taking any of the following medications prior to admission or at the time of evaluation? |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:56:57.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58978 | Medication beta-blocker past week type | MedctnBetaBlockerPastWkTyp | Type of beta-blocker medication taken by the subject/participant within the past week | Type of beta-blocker medication taken by the subject/participant within the past week | If beta-blocker history, indicate medication(s) the patient took within the past week | Propranolol;Atenolol;Metoprolol;Carvedilol;Other, specify | Propranolol;Atenolol;Metoprolol;Carvedilol;Other, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 11:39:46.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C54996 | Potency enhancing drug current former use age start value | PtncyEnhcgDrgCurFmrUsAgStrtVal | Age in years at which the subject/participant began taking the specified former or current potency-enhancing drug | Age in years at which the subject/participant began taking the specified former or current potency-enhancing drug | Age when use started (years) | Numeric Values |
No instructions available |
No references available | Adult;Pediatric | Exploratory | 1.00 | 2017-04-13 14:32:36.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Free-Form Entry |
Years | |||||||||
| C58989 | Medication hormone replacement past week type | MedctnHrmneRplcmtPastWkTyp | Type of hormone replacement medication taken by the subject/participant within the past week | Type of hormone replacement medication taken by the subject/participant within the past week | If YES, indicate medication(s) the patient took within the past week | Estrogen;Combination of Estrogen and Progesterone;Progesterone;Testosterone;Other, specify | Estrogen;Combination of Estrogen and Progesterone;Progesterone;Testosterone;Other, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 14:12:54.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C59000 | Medication L-asparaginase current former take indicator | MedctnLASPCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken L-asparaginase | The indicator relating to whether the subject/participant has formerly or currently taken L-asparaginase | L-asparaginase | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
This element is recommended for pediatric stroke studies. |
No references available | Pediatric | Exploratory | 1.00 | 2020-08-13 15:43:06.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58968 | Medication cholesterol reduce control past week type | MedctnCholRdcCtrlPastWkTyp | Type of cholesterol-reducing/ controlling medication taken by the subject/participant within the past week | Type of cholesterol-reducing/ controlling medication taken by the subject/participant within the past week | If YES, indicate medication(s) the patient took within the past week | Statin;Fibrate;Ezetimibe;Other, specify | Statin;Fibrate;Ezetimibe;Other, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:44:18.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C54986 | Stimulant current former use other text | StimulantCurrFrmrUseOTH | The free-text field related to 'Stimulant current former use type' specifying other text | The free-text field related to 'Stimulant current former use type' specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 14:30:43.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 50 |
Free-Form Entry |
|||||||||
| C58979 | Medication beta-blocker past week other text | MedctnBetaBlockerPastWkOTH | The free-text field related to 'Medication beta-blocker past week type', specifying other text | The free-text field related to 'Medication beta-blocker past week type', specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 13:14:14.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C54997 | Potency enhancing drug former use age end value | PotncyEnhancgDrugFmrUsAgEndVal | Age in years at which the subject/participant stopped taking the specified potency-enhancing drug | Age in years at which the subject/participant stopped taking the specified potency-enhancing drug | Age when use ended (years) | Numeric Values |
No instructions available |
No references available | Adult;Pediatric | Exploratory | 1.00 | 2017-04-13 14:32:36.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Free-Form Entry |
Years | |||||||||
| C58990 | Medication hormone replacement past week other text | MedctnHrmneRplcmtPastWkOTH | The free-text field related to 'Medication hormone replacement past week type', specifying text | The free-text field related to 'Medication hormone replacement past week type', specifying text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 14:18:32.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C58969 | Medication cholesterol reduce control past week other text | MedctnCholRdcCtrlPastWkOTH | The free-text field related to 'Medication cholesterol reduce control past week type', specifying other text | The free-text field related to 'Medication cholesterol reduce control past week type', specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:45:06.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C54987 | Stimulant current former use duration | SimulantCurFrmrUseDur | Duration in months for which the subject/participant took or has taken the selected former or current stimulant | Duration in months for which the subject/participant took or has taken the selected former or current stimulant | Duration of Use (months) | Numeric Values |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 14:32:36.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Free-Form Entry |
Months | |||||||||
| C58980 | Medication angiotensin receptor blocker past week type | MedctnAngtsnRcptrBlkrPastWkTyp | Type of angiotensin receptor blocker (ARB) medication taken by the subject/participant within the past week | Type of angiotensin receptor blocker (ARB) medication taken by the subject/participant within the past week | If angiotensin receptor blocker (ARB) history, indicate medication(s) the patient took within the past week | Candesartan;Losartan;Other, specify | Candesartan;Losartan;Other, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 13:15:16.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C54998 | Medication immunosuppressant current former type | MedctnImnosprsntCurrFrmrTyp | Type of immunosuppressant medication formerly or currently taken by the subject/participant | Type of immunosuppressant medication formerly or currently taken by the subject/participant | Immunosuppressants | Corticosteroids local;Corticosteroids systemic;Other, specify: | Corticosteroids local;Corticosteroids systemic;Other, specify: | Alphanumeric |
Was the participant/ subject taking any of the following medications prior to admission or at the time of evaluation? |
No references available | Adult;Pediatric | Exploratory | 1.00 | 2017-04-13 13:56:57.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58991 | Medication hormone replacement therapy route type | MedctnHrmneRplcmtTherpyRteTyp | Type of administration route for the hormone replacement therapy medication taken by the subject/participant within the past week | Type of administration route for the hormone replacement therapy medication taken by the subject/participant within the past week | If YES, indicate the route of hormonal replacement therapy | Oral;Topical;Transdermal;Other, specify;Unknown | Oral;Topical;Transdermal;Other, specify;Unknown | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 14:20:24.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C58970 | PCSK9 inhibitor past three month indicator | PCSK9InhibitorPastThreeMoInd | The indicator related to whether the subject/participant was taking PCSK9 inhibitors (alirocumab, evolocumab) within the past three months | The indicator related to whether the subject/participant was taking PCSK9 inhibitors (alirocumab, evolocumab) within the past three months | If YES, was patient taking PCSK9 inhibitors within past three months (alirocumab, evolocumab) | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:45:46.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C54988 | Stimulant current former use age start value | StimulantCurFmrUsAgSttVal | Age in years at which the subject/participant began taking the selected former or current stimulant | Age in years at which the subject/participant began taking the selected former or current stimulant | Age at Start (years) | Numeric Values |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 14:32:36.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Free-Form Entry |
Years | |||||||||
| C58981 | Medication angiotensin receptor blocker past week other text | MedctnAngtRtrBlkrPastWkOTH | The free-text field related to 'Medication angiotensin receptor blocker past week type', specifying other text | The free-text field related to 'Medication angiotensin receptor blocker past week type', specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 13:23:35.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C54999 | Medication immunosuppressant current former take other text | MedctnImnosprsntCurrFrmrTkOTH | The free-text field related to 'Medication immunosuppressant current former type' specifying other text | The free-text field related to 'Medication immunosuppressant current former type' specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Exploratory | 1.00 | 2017-04-13 14:30:43.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C58992 | Medication hormone replacement therapy route other text | MedctnHrmnRplcmThrpyRteOTH | The free-text field related to 'Medication hormone replacement therapy route type', specifying text | The free-text field related to 'Medication hormone replacement therapy route type', specifying text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 14:31:46.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C58971 | Medication diabetic current former take indicator | MedctnDiabeticCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken diabetic medications | The indicator relating to whether the subject/participant has formerly or currently taken diabetic medications | Diabetic medications | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation? |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:46:43.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C54989 | Stimulant former use age end value | StimulantFmrUseAgEndVal | Age in years at which the subject/participant stopped taking the selected former stimulant | Age in years at which the subject/participant stopped taking the selected former stimulant | Age at End (years) | Numeric Values |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 14:32:36.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Free-Form Entry |
Years | |||||||||
| C58982 | Medication calcium-channel blocker past week type | MedctnCaChannlBlockerPastWkTyp | Type of calcium-channel blocker medication taken by the subject/participant within the past week | Type of calcium-channel blocker medication taken by the subject/participant within the past week | If calcium-channel blocker history, indicate medication(s) the patient took within the past week | Verapamil;Felodipine;Amlodipine;Diltiazem;Other, specify | Verapamil;Felodipine;Amlodipine;Diltiazem;Other, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 13:25:08.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C58961 | Medication antiplatelet current former take indicator | MedctnAntiplatltCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken antiplatelet medications | The indicator relating to whether the subject/participant has formerly or currently taken antiplatelet medications | Antiplatelets | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation? |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:24:19.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58993 | Medication oral contraceptive current former take indicator | MedctnOrlCntrcptvCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken oral contraceptives | The indicator relating to whether the subject/participant has formerly or currently taken oral contraceptives | Oral contraceptives | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation? |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 14:32:39.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58972 | Medication diabetic past week type | MedctnDiabeticPastWkTyp | Type of diabetic medication taken by the subject/participant within the past week | Type of diabetic medication taken by the subject/participant within the past week | If YES, indicate medication(s) the patient took within the past week | 2nd generation sulfonylurea (glyburide, glipizide, glimepiride);Thiazolidinedione (rosiglitazone, pioglitazone);Repaglinide/ Nateglinide;Insulin;Metformin;Acarbose;1st generation sulfonylurea (chlorpropamide);Other, specify | 2nd generation sulfonylurea (glyburide, glipizide, glimepiride);Thiazolidinedione (rosiglitazone, pioglitazone);Repaglinide/ Nateglinide;Insulin;Metformin;Acarbose;1st generation sulfonylurea (chlorpropamide);Other, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:48:14.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C54990 | Cocaine expose year prior unruptured intracranial aneurysm presentation indicator | CokeExposeYearPriorUIAPrsntInd | Indicator of whether the subject/participant was exposed to cocaine in the year prior to clinical presentation of unruptured intracranial aneurysm (UIA) | Indicator of whether the subject/participant was exposed to cocaine in the year prior to clinical presentation of unruptured intracranial aneurysm (UIA) | Cocaine: Exposure to cocaine within one year of clinical presentation of UIA | No;Yes | No;Yes | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 15:52:12.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58983 | Medication calcium-channel blocker past week other text | MedctnCaChnlBlckrPastWkOTH | The free-text field related to 'Medication calcium-channel blocker past week type', specifying other text | The free-text field related to 'Medication calcium-channel blocker past week type', specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 13:36:15.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C58962 | Medication antiplatelet past week type | MedctnAntiplatltPastWkTyp | Type of antiplatelet medication taken by the subject/participant within the past week | Type of antiplatelet medication taken by the subject/participant within the past week | If YES, indicate medication(s) the patient took within the past week | ASA/Dipyridamole (in separate formulations or as Aggrenox);Aspirin (ASA);Clopidogrel (Plavix);Cilostazol (Pletal);Ticlopidine (Ticlid);Ticagrelor (Brilinta);Prasugrel (Effient);Other, specify;Pentoxifylline (Trental) | ASA/Dipyridamole (in separate formulations or as Aggrenox);Aspirin (ASA);Clopidogrel (Plavix);Cilostazol (Pletal);Ticlopidine (Ticlid);Ticagrelor (Brilinta);Prasugrel (Effient);Other, specify;Pentoxifylline (Trental) | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:26:49.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C58994 | Medication implant estrogen contraceptive current former take indicator | MedctnImpEstCtrcpCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken implanted, estrogen-containing contraceptives | The indicator relating to whether the subject/participant has formerly or currently taken implanted, estrogen-containing contraceptives | Implanted, estrogen-containing contraceptives | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation? |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 14:34:08.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58973 | Medication diabetic past week other text | MedctnDiabeticPastWkOTH | The free-text field related to 'Medication diabetic past week type', specifying other text | The free-text field related to 'Medication diabetic past week type', specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 11:10:34.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C54991 | Cocaine use duration | CocaineUseDur | Duration in months for which the subject/participant took or has taken cocaine | Duration in months for which the subject/participant took or has taken cocaine | Duration of Use (months) | Numeric Values |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 14:32:36.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Free-Form Entry |
Months | |||||||||
| C58984 | Medication ACE inhibitor past week type | MedctnACEInhibitorPastWkTyp | Type of ACE (angiotensin-converting enzyme) inhibitor medication taken by the subject/participant within the past week | Type of ACE (angiotensin-converting enzyme) inhibitor medication taken by the subject/participant within the past week | If ACE inhibitor history, indicate medication(s) the patient took within the past week | Enalapril;Lisinopril;Fosinopril;Ramipril (Altace);Captopril;Other, specify | Enalapril;Lisinopril;Fosinopril;Ramipril (Altace);Captopril;Other, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 13:37:30.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C58995 | Medication other current former take indicator | MedctnOthrCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken other medications | The indicator relating to whether the subject/participant has formerly or currently taken other medications | Any other medications not already listed | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 15:17:35.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58963 | Medication antiplatelet past week other text | MedctnAntiplatltPastWkOTH | The free-text field related to 'Medication antiplatelet past week type', specifying other text | The free-text field related to 'Medication antiplatelet past week type', specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:32:41.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C58974 | Medication antihypertensive current former take indicator | MedctnAntihyprtnsCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken antihypertensive medications | The indicator relating to whether the subject/participant has formerly or currently taken antihypertensive medications | Antihypertensive medications | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation? |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 11:12:02.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C54992 | Cocaine exposure age start value | CocaineExposureAgeStartVal | Age in years at which the subject/participant began exposure to cocaine | Age in years at which the subject/participant began exposure to cocaine | Age when use started (years) | Numeric Values |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 14:32:36.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Free-Form Entry |
Years | |||||||||
| C58985 | Medication ACE inhibitor past week other text | MedctnACEInhibitrPastWkOTH | The free-text field related to 'Medication ACE inhibitor past week type', specifying other text | The free-text field related to 'Medication ACE inhibitor past week type', specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 13:48:16.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C58996 | Medication other past week type | MedctnOthrPastWkTyp | Type of other medication taken by the subject/participant within the past week | Type of other medication taken by the subject/participant within the past week | Type of other medication taken by the subject/participant within the past week | Digoxin/cardiac glycosides;Thyroid preparations;Benzodiazepines (Valium, Librium, Ativan, Xanax);Anti-Parkinsonian meds (including selegiline);Non-aspirin salicylates (salsalate);Other nonsteroidal anti-inflammatory drugs;Ginkgo derivatives/other herbals;Vitamin E (more than multivitamins);SSRIs and new-generation antidepressants;Antiarrhythmic drugs (quinidine, amiodarone);Tricyclic antidepressants (amitriptyline, imipramine, doxepin);H2 blocker (e.g., cimetidine) or proton pump inhibitor (e.g., omeprazole);Donepezil and related meds;Analgesics (acetaminophen, codeine)–daily;COX 2 inhibitors (e.g., celecoxib);COX inhibitors (e.g., ibuprofen, naproxen);Multivitamin;Other, specify;Nitrates | Digoxin/cardiac glycosides;Thyroid preparations;Benzodiazepines (Valium, Librium, Ativan, Xanax);Anti-Parkinsonian meds (including selegiline);Non-aspirin salicylates (salsalate);Other nonsteroidal anti-inflammatory drugs;Ginkgo derivatives/other herbals;Vitamin E (more than multivitamins);SSRIs and new-generation antidepressants;Antiarrhythmic drugs (quinidine, amiodarone);Tricyclic antidepressants (amitriptyline, imipramine, doxepin);H2 blocker (e.g., cimetidine) or proton pump inhibitor (e.g., omeprazole);Donepezil and related meds;Analgesics (acetaminophen, codeine)–daily;COX 2 inhibitors (e.g., celecoxib);COX inhibitors (e.g., ibuprofen, naproxen);Multivitamin;Other, specify;Nitrates | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 15:21:26.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C58964 | Medication anticoagulant current former take indicator | MedctnAnticoaglntCurrFrmrTkInd | The indicator relating to whether the subject/participant has formerly or currently taken anticoagulant medications | The indicator relating to whether the subject/participant has formerly or currently taken anticoagulant medications | Anticoagulants | No;Yes;Unknown | No;Yes;Unknown | Alphanumeric |
Was the participant/ subject taking the following medication prior to admission or at the time of evaluation? |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:35:40.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C12207 | Gastrointestinal therapy take nutrition supplement indicator | GITherTakeNutritionSupplInd | Indicator whether the participant/subject is taking nutritional supplements | Indicator whether the participant/subject is taking nutritional supplements | Taking supplements | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Exploratory | 3.00 | 2013-07-24 11:38:01.2 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58975 | Medication antihypertensive past week type | MedctnAntihyprtnsvPastWkTyp | Type of antihypertensive medication taken by the subject/participant within the past week | Type of antihypertensive medication taken by the subject/participant within the past week | If YES, indicate medication(s) the patient took within the past week | Angiotensin receptor blocker;Calcium-channel blocker;Beta-blocker;Diuretic;ACE inhibitor;Potassium supplement;Other | Angiotensin receptor blocker;Calcium-channel blocker;Beta-blocker;Diuretic;ACE inhibitor;Potassium supplement;Other | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 11:15:00.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C54993 | Cocaine exposure age end value | CocainExposureAgEndVal | Age in years at which the subject/participant's exposure to cocaine ended | Age in years at which the subject/participant's exposure to cocaine ended | Age when use ended (years) | Numeric Values |
No instructions available |
No references available | Adult;Pediatric | Exploratory | 1.00 | 2017-04-13 14:32:36.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Free-Form Entry |
Years | |||||||||
| C58986 | Medication other antihypertensive past week type | MedctnOthrAnthyprtnsvPastWkTyp | Type of other antihypertensive medication taken by the subject/participant within the past week | Type of other antihypertensive medication taken by the subject/participant within the past week | If other medication history, indicate medication(s) the patient took within the past week | Central alpha agonists (clonidine);Alpha-blockers (prazosin, terazosin);Vasodilator: minoxidil;Vasodilator: hydralazine;Other antihypertensive, specify | Central alpha agonists (clonidine);Alpha-blockers (prazosin, terazosin);Vasodilator: minoxidil;Vasodilator: hydralazine;Other antihypertensive, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 13:56:42.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C58997 | Medication other past week other text | MedctnOthrPastWkOTH | The free-text field related to 'Medication other past week type', specifying other text | The free-text field related to 'Medication other past week type', specifying other text | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 15:39:18.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C58965 | Medication anticoagulant past week type | MedctnAnticoaglntPastWkTyp | Type of anticoagulant medication taken by the subject/participant within the past week | Type of anticoagulant medication taken by the subject/participant within the past week | If YES, indicate medication(s) the patient took within the past week | Dabigatran (Pradaxa);Edoxaban (Savaysa);Other, specify;Acenocoumarol;Betrixaban (Bevyxxa);Rivaroxaban (Xarelto);Full dose LMW heparin (Enoxaparin, Others);Apixaban (Eliquis);Unfractionated heparin IV;Warfarin (Coumadin);Fondaparinux (Arixtra);Phenprocoumon | Dabigatran (Pradaxa);Edoxaban (Savaysa);Other, specify;Acenocoumarol;Betrixaban (Bevyxxa);Rivaroxaban (Xarelto);Full dose LMW heparin (Enoxaparin, Others);Apixaban (Eliquis);Unfractionated heparin IV;Warfarin (Coumadin);Fondaparinux (Arixtra);Phenprocoumon | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-07-30 16:40:13.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C12208 | Gastrointestinal therapy nutrition supplement type | GITherpyNutritionSupplementTyp | Type(s) of nutritional supplement(s) being taken by the participant/subject | Type(s) of nutritional supplement(s) being taken by the participant/subject | Type(s) of supplements | Beta Carotene;Calcium;Dehydroepiandrosterone (DHEA);Echinacea;Flax Seed Oil;Folic Acid;Ginkgo;Ginseng;Saw Palmetto;Soy Protein Powder;Soy Supplements;St. John's Wort;Vitamin A;Vitamin C;Vitamin E;Weight Loss Supplements;Wheat Germ;Turmeric;Fiber;Creatine;CoQ10;Other, specify | Beta Carotene;Calcium;Dehydroepiandrosterone (DHEA);Echinacea;Flax Seed Oil;Folic Acid;Ginkgo;Ginseng;Saw Palmetto;Soy Protein Powder;Soy Supplements;St. John's Wort;Vitamin A;Vitamin C;Vitamin E;Weight Loss Supplements;Wheat Germ;Turmeric;Fiber;Creatine;CoQ10;Other, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Exploratory | 3.00 | 2013-07-24 11:38:01.2 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
2183828 | |||||||
| C58976 | Medication diuretic past week type | MedctnDiureticPastWkTyp | Type of diuretic medication taken by the subject/participant within the past week | Type of diuretic medication taken by the subject/participant within the past week | If diuretic history, indicate medication(s) the patient took within the past week | Thiazides (HCTZ, chlorthalidone);Furosemide/ loop diuretic;Potassium sparing;Other, specify | Thiazides (HCTZ, chlorthalidone);Furosemide/ loop diuretic;Potassium sparing;Other, specify | Alphanumeric |
Choose all that apply |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-08-13 11:22:05.0 | Prior and Concomitant Medications | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
